BIBLIOGRAFIA
[1] Aguggini G. Respirazione, in Aguggini Beghelli Giulio “Fisiologia degli animali domestici con elementi di etologia”, p. 488, 2o ed., ed. UTET, Torino, 1998.
[2] Aster JC. Malattie dei globuli rossi ed emorragiche, in Robbins e Cotran “Le basi patologiche delle malattie”, pp. 620-622, 7o ed., Ed Elsevier, Milano, 2005.
[3] Barbui T, Finazzi G. Risk factors and prevention of vascular complications in polycythemia vera. Semin Thromb Hemost, 1997; 23: 455-461.
[4] Barbui T. Policitemia vera. Haemat Rep, 2006; 2 (6): 32-35.
[5] Bergamaschi R, Caldin M, Contoga P, Furlanello T. L’eritrocitosi nel gatto: presentazione di un caso clinico e monitoraggio a lungo termine della terapia con idrossiurea. Veterinaria, 20 (3): 39-43, 2006.
[6] Bessis M. Living blood cells and their ultrastructure. Sprinter-Verlag, New York, 1973.
[7] Beutler E. Polycythemia, in Williams “Hematology”, 6o edizione, pp. 689-699, Ed Mc Graw Hill, 2001.
[8] Beutler E. Production and destruction of erythrocytes, in Williams “Hematology”, 6o edizione, pp. 355-365, Ed Mc Graw Hill, 2001.
[9] Camba L. Malattie del sangue e degli organi emolinfopoietici, in Rugarli “Medicina Interna Sistematica”, pp. 751-768, 4° edizione, Ed. Masson, 2001.
[10] Camba L. Policitemia Rubra Vera, in Rugarli “Medicina Interna Sistematica”, pp. 855-858, 4° edizione, Ed. Masson, 2001.
[11] Car BD. Erythropoiesis and Erythokinetics, in Shalm’s “Veterinary Hematology”, 5° edition, pp 105-109, Ed Lippincott Williams & Wickins, Baltimore, 2000.
[12] Cazzola M, Beguin Y. New tools for clinical evaluation of erythropoiesis and iron status in man. Br J Haematol, 1992; 82: 278.
[13] Cazzola M. Somatic mutations of JAK2 exon 12 as a molecular basis of erythrocytosis. Haematologica, 2007; 92 (12): 1585-1589.
[14] Clement MG. Sistema Eritrogenina-Eritropoietina, in Aguggini Beghelli Giulio “Fisiologia degli animali domestici con elementi di etologia”, pp. 636-637, 2o ed., 1998, ed. UTET, Torino.
[15] Conrad KP, Benyo DF, Westerhausen-Larsen A, Miles TM. Expression of erythropoietin by the human placenta. FASEB J, 1996; 10: 760-766.
[16] Cook SM, Lothrop CD Jr. Serum erythropoietin concentrations measured by Radioimmunoassay in normal, polycythemic, and anemic dogs and cats. J Vet Inter Med, 1994; 8: 18-25.
[17] Cordiano V. Il midollo emopoietico, sito italiano di ematologia, 2004.
[18] Couto CG, Boudrieau RJ, Zanjani ED. Tumour associated erythrocitosis in a dog with nasal fibrosarcoma. J Vet Inter Med, 1989; 3: 183-185.
[19] Couto CG. Eritrocitosi, in Nelson Couto “Medicina interna del cane e del gatto”, 3o ed., pp. 1200-1202, ed. Elsevier, 2006.
[20] Crow SE, Allen DP, Murphy CJ, Culbertson R. Concurrent renal adenocarcinoma and polycythaemia in a dog. J Am Anim Hosp Assoc, 1995; 31: 29-33.
[21] Danova M, Aglietta M. Cytokine receptors growth factors and cell cycle in humane bone marrow and peripheral blood hematopoietic progenitors. Seminars of the italian society of experimental haematology, Haematologica 1997; 82: 622-629.
[22] Da Silva J, Lacombe C, Bruneval P et al. Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia. Blood, 1990; 75 (3): 577-582.
[23] Dean GA. Cytokine Regulation of Hemopoiesis, in Shalm’s “Veterinary Hematology”, 5° edition, pp 69-73, Ed Lippincott Williams & Wickins, Baltimore, 2000.
[24] de la Chapelle A, Traskelin AL, Juconen E. Tryuncated erythropoietin receptor causes dominantly inherited benign human erytropoiesis. Proc Natl Acad Sci USA, 1993; 90: 4495-4499.
[25] Dexter TM. Regulation of hemopoietic cell growth and development: experimental and clinical studies. Leukemia 1989; 3: 469-474.
[26] Digicaylioglu M, Bichet S, Marti HH, Wenger RH, Rivas L, Bauer C, Gassman M. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci USA, 1995; 92: 3717-3720.
[27] Erslev AJ. Clinical erythrokinetics: a critical review. Blood Rev, 1997, 11: 160-167.
[28] Erslev AJ. Clinical manifestations and classification of erythrocyte disorders, in Williams “Hematology”, 6o edizione, pp. 369-374, Ed Mc Graw Hill, 2001.
[29] Evans LM, Caylor KB. Polycythemia Vera in a Cat and Management with Hydroxyurea. J Am Anim Hosp Assoc, 1995; 31: 434-438.
[30] Facello C, Guglielmino R. Emoglobina, in Aguggini Beghelli Giulio “Fisiologia degli animali domestici con elementi di etologia”, pp. 324-326, 2o ed., 1998, ed. UTET, Torino.
[31] Faquin WC, Schneider TJ, Goldberg MA. Effect of infiammatory cytokines on hypoxia-induced erythropoietin production. Blood, 1992; 79 (8): 1987-1994.
[32] Fisher JW. Erythropoietin: physiologic and pharmacologic aspect. Soc Exp Biol Med, 1997; 216: 358.
[33] Foster ES, Lothrop CD Jr. Polycythemia vera in a cat with cardiac hypertrophy. J Am Vet Medic Assoc, 1988; 192: 1736-1738.
[34] Fukamachi H, Urabe A, Saito T, Takaku F, Kubota M. Burst promoting activity in anemia and polycythemia, Int J Cell Cloning, 1986; 4: 74-81.
[35] Gaines Das RE, Milne A, Rowley M, Gordon-Smith EC, Cotes PM. Serum immunoreactive erythropoietin in patients with idiopathic aplastic and Fanconi’s anemia. Br J Haematol, 1992; 82: 601.
[36] Gasper PW. Hemopoietic Microenvironment, in Shalm’s “Veterinary Hematology”, 5° edition, pp 69-73, Ed Lippincott Williams & Wickins, Baltimore, 2000.
[37] Gasper PW. Sistem Cell Biology, in Shalm’s “Veterinary Hematology”, 5° edition, pp. 69-73, Ed Lippincott Williams & Wickins, Baltimore, 2000.
[38] Gasper PW. The Hemopoietic System, in Shalm’s “Veterinary Hematology”, 5° edition, pp. 69-73, Ed Lippincott Williams & Wickins, Baltimore, 2000.
[39] Gordon MY, Riley GP, Watt SM, Greaves MF. Compartimentalization of a haemopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 1987; 326: 403-405.
[40] Gorse MJ. Policythaemia associated with renal fibrosarcoma in a dog. J Am Vet Med Assoc, 1998; 192: 793-794.
[41] Gromo G. Le poliglobulie e la trombocitosi, in Rugarli “Medicina Interna Sistematica”, pp. 831-835, 4° edizione, Ed. Masson, 2001.
[42] Hanspal M. Importance of cell-cell interactions in regulation of erythropoiesis. Curr Op Hematol, 1997; 4: 142-147.
[43] Hasler AH, Giger U. Policitemia, in Ettinger Feldmann “Trattato di Clinica Medica Veterinaria Malattie del cane e del gatto”, pp. 203-206, 2o ed., Antonio Delfino Editore, 2001.
[44] Hasler AH, Giger U. Serum erythropoietin values in policythaemic cats. J Am Anim Hosp Assoc, 1996; 32: 294-301.
[45] http://www.infettivibrescia.it/schede_HIV/terapia/farv_altri/AltriFarmaci_HU.html.
[46] http://www.virbacpet.it/content/mos/Frontpage
[47] Joneja B, Wojchowski DM. Mitogenic signaling and inhibition of apoptosis via the erythropoietin receptor Box-1 domain. J Biol Chem, 1997; 272: 11176.
[48] Jonhson CM, Gengonzian N, Mergia A. Hematopoiesis in the feline fetal liver: an assessment by flow cytometry. Vet Immun Immunopath, 2004; 99(1-2): 53-62.
[49] Kaneko JJ, Mattheeuws DRG. Iron metabolism in normal and porphyric calves. Amer J Vet Res, 1966; 27: 923-929.
[50] Kaneko JJ, Zinkl JG, Keeton KS. Erythrocyte porphyrin and erythrocyte survival in bovine erythropoietin porphrya. Am J Vet Res, 1971; 32: 1981-1985.
[51] Kendall RG, Cavill I, Norfolk DR. Serum erythropoietin levels during haematinic therapy. Br J Haematol, 1992; 81: 630.
[52] Khanna C, Bienzle D. Polycythemia vera in a cat: bone marrow culture in erythropoietin-deficient medium. J Am Anim Hosp Assoc, 1994; 30: 45-49.
[53] Khera KS. A teratogenicity study on hydroxyurea and diphenylhydantoin in cats. Teratology, 1979; 20 (3): 447-452.
[54] Kirby D, Gillick A. Polycythemia and Tetralogy of Fallot in a Cat. Can Vet Jour, 1974; 15 (4): 114-119.
[55] Klein MK, Cockrell GL, Withrow SJ. Canine primary renal neoplasms: a retrospective reviw of 54 cases. J Am Anim Hosp Assoc, 1998; 24: 443-452.
[56] Krantz SB. Erythropoietin. Blood, 1991; 77 (3): 419-434.
[57] Lazzarino M, Passamonti F. Policitemia vera: terapie efficaci con buona qualità di vita. Sito internet: http://www.ematologia-pavia.it/Terapie/Policitemia.htm
[58] Lazzarino M, Passamonti F. Treatment of polycythemia vera and essential thrombocythemia: the role of pipobroman. Leuk Lymphoma, 2003; 44 (9): 1483-1488.
[59] Lin CS, Lim SK, D’Agati V, Costantini F. Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev, 1996; 10: 154.
[60] Lubas G. Approccio orientato al problema e sue varianti, in Lubas “Medicina Interna Veterinaria: Procedure Cliniche e Casi clinici secondo il POA”, pp. 24-28, 2o ed., Pisa, SEU, 2006.
[61] Lubas G. Inquadramento diagnostico delle anemie, in Lubas “Appunti di Ematologia Clinica Veterinaria: disordini degli eritrociti e dei leucociti”, p. 15, 1o ed., Pisa, SEU, 2005.
[62] Lubas G. Policitemia (Eritrocitosi), in Lubas “Appunti di Ematologia Clinica Veterinaria: disordini degli eritrociti e dei leucociti”, pp. 52-53, 1o ed., Pisa, SEU, 2005.
[63] Lubas G. Richiami sull’eritrone, in Lubas “Appunti di Ematologia Clinica Veterinaria: disordini degli eritrociti e dei leucociti”, pp. 6-13, 1o ed., Pisa, SEU, 2005.
[64] Ludwing H, Fritz E, Leitgeb C, Pecherstorfer M, Samonigg H, Schuster J. Prediction of response to erythropoietin treatment in chronic anemia of cancer. Blood, 1994; 84: 1056-1063.
[65] Marti HH, Wenger RH, Rivas L, Straumann U, Digicaylioglu M, Henn V, Yonekawa Y, Bauer C, Gassman M. Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci, 1996; 8: 666-676.
[66] Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, Sasaki R. A novel site of erythropoietin production. J Biol Chem, 1994; 269: 19488-19493.
[67] Maury CP, Andersson LC, Teppo AM, Partanen S, Juvonen E. Mechanisms of anemia in rheumathoid arthritis: demonstration of raised interleukin-1 beta concentrations in anaemic patients and of interleukin-1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro. Ann Rheum Dis, 1988; 47: 972-978.
[68] Means RT Jr, Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood, 1992; 80: 1639-1647.
[69] Mock DM, Lankford GL, Burmeister LF, Strauss RG. Circulating red cell volume and red cell survival can be accurately determined in sheep using the [14C]cyanate label. Pediatr Res, 1997; 41: 916-921.
[70] Moritz KM, Lim GB, Wintour EM. Developmental regulation of erythropoietin and erythropoiesis. Am J Physiol, 1997; 273: 1829-1844.
[71] Morrison SJ, Shah NM, Anderson DJ. Regulatory mechanisms in stem cell biology. Cell 1997; 88: 287-298.
[72] Najean Y, Rain JD. Treatment of polycythemia vera: The use of hydroxyurea and pipobroman in 292 patients under the age of 65 years. Blood, 1997; 90: 3370-3377.
[73] Nakamura Y, Nakauchi H. A truncated erythropoietin receptor and cell death: a reanalysis. Science, 1994; 264: 588-589.
[74] Nelson RW, Hager D, Zanjani ED, Renal lymphosarcoma with inappropriate erythropoietin production in a dog. J Am Vet Med Assoc, 1983; 182: 1396-1397.
[75] Nett CS, Arnold P, Glaus TM. Leeching as initial treatment in a cat with polycythaemia vera. J Sm Anim Pract, 2001; 42: 554-556.
[76] Nitsche EK. Erythrocytosis in Dogs and Cats: Diagnosis and Management. Comp on contin educ for the pratic vet, 2004; 26 (2): 104-118.
[77] Orkin SH. Transcription factors and hematopoietic development. J Biol Chem, 1995; 270: 4955-4958.
[78] Partanen S, Juvonen E, Ikkala E, Ruutu T. Spontaneus erythroid colony formation in the differential diagnosis of erythocitosis. Eur J Haematol, 1989; 42: 327-330.
[79] Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, Boggs SS, Greenberger JS, Goff JP. Bone Marrow as a Potential Source of Hepatic Oval Cells. Science 1999; 284:1168-1170.
[80] Peterson ME, Randolph JF. Diagnosis and treatment of polycythemia. In Kirk RW (ed): Current Vet Therapy VIII. Philadelphia, WB Saunders, 1983, pp. 406-408.
[81] Peterson ME, Randolph JF. Diagnosis of canine primary polycythaemia and management with hydroxyurea. J Am Vet Med Assoc, 1982; 180: 415-418.
[82] Peterson ME, Zanjani ED. Inappropriate erythropoietin production from a renal carcinoma in a dog with polycythaemia. J Am Vet Med Assoc, 1981; 179 (10): 995-996.
[83] Peterson P, Wasserman LR. The natural history of polycythemia vera, in Wasserman Berk Berlin “Polycythemia vera and the myeloproliferative disorders”, Philadelphia: WB Saunders, 1995, pp. 14-49.
[84] Plumb DC, Plumb’s Veterinary Drug Handbook, 5oed., Ames, Iowa, Blackwell Publishing, 2005, pp. 401-402.
[85] Porter DL, Goldberg MA. Physiology of erythropoietin production. Seminars Hematol, 1994; 31: 112-121.
[86] Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276:71-74.
[87] Reed C, Ling GV, Gould D, Kaneko JJ. Polycythemia Vera in a Cat. J Am Vet Med Assoc, 1970; 157 (1): 85-91.
[88] Rosati P, Colombo R. Emopoiesi, in Rosati Colombo “Istologia”, 4o ed., pp. 517-534, Edi-Ermes, 2003.
[89] Sawyer ST, Penta K. Erythropoietin cell biology. Hematol Oncol Clin North Am, 1994; 8: 895.
[90] Schrezenmeier H, Noè G, Raghavacar A, Rich IN, Heimpel H, Kubanek B. Serum erythropoietin and serum transferrin receptor levels in aplastic anaemia. Br J Haematol, 1994; 88: 286.
[91] Scott RC, Patnaik AK. Renal carcinoma with secondary polycythaemia in a dog. J Am Anim Hosp Ass, 1972; 8: 275-283.
[92] Semenza GL. Regulation of erythropoietin production: new insights into molecular mechanism of oxigen homeostasis. Hematol/Oncol Clin North Am, 1994; 8: 863-884.
[94] Silver RT. Long-Term Effects of the Treatment of Polycythemia Vera With Recombinant Interferon-α. Cancer, 2006; 107 (3): 451-458.
[95] Simmons PJ, Zannettino A, Gronthos S, Leavesley D. Potential adhesion mechanisms for localisation of haemopoietic progenitors to bone marrow stroma. Leukemia and Lymphoma, 1994; 12: 353-363.
[96] Smith M, Turrel JM. Radiophosphorus treatment of bone marrow disorders in dogs: 11 cases (1970-1987). J Am Vet Med Assoc, 1989; 194: 98-102.
[97] Souyri M. Mpl: from an acute myeloproliferative virus to the isolation of the long sought thrombopoietin. Semin Hematol, 1998; 35: 222-231.
[98] Spivak JL, Pham T, Isaacs M, Hankins WD. Erythropoietin is both a mitogen and a survival factor. Blood, 1991; 77: 1228.
[99] Stuart BJ, Viera AJ. Polycythemia vera. Am Fam Physician, 2004; 69 (9): 2139-2144.
[100] Tan CC, Eckardt K, Firth JD, Ratcliffe PJ. Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol, 1992; 263: R474-R481.
[101] Tomasello R. Nuove strategie terapeutiche e Qualità di Vita in Oncologia: dalla clinica alla bioetica, Prevenzione degli effetti tossici: antiemetici e fattori di crescita. Messina: 9-10 marzo 2001, sito internet.
[102] Torrance A. Inclusioni eritrocitarie, in Day Mackin Littlewood “Ematologia e medicina trasfusionale del cane e del gatto”, p. 12, ed. UTET, 2004.
[103] Trentin JJ. Influence of hematopoietic organ stroma (hematopoietic inductive microenvironments) on stem cell differentiation, in Gordon AS (ed): Regulation of Hematopoiesis (vol 1). New York, NY, Appleton, 1970, pp. 161-185.
[104] Villiers E. Policitemia, in Day Mackin Littlewood “Ematologia e medicina trasfusionale del cane e del gatto”, pp. 47-54, ed. UTET, 2004.
[105] Walker D. Sangue periferico, in Cowell Tyler Meinkoth “Citologia diagnostica ed Ematologia del cane e del gatto”, pp.268-269, ed. UTET, 2001.
[106] Waters DJ, Prueter JC. Secondary polycythaemia associated with renal disease in a dog: two case reports and review of literature. J Am Anim Hosp Ass, 1986; 31: 29-33.
[107] Watson ADJ. Erythrocitosis and Polycythemia, in Shalm’s “Veterinary Hematology”, 5° edition, pp. 216-221, Ed Lippincott Williams & Wickins, Baltimore, 2000.
[108] Watson ADJ, Moore AS, Helfand SC. Primary erythrocytosis in the cat: Treatment with hydroxyurea. J Small Anim Pract, 1994; 35: 320-325.
[109] Withrow SJ. Tumours of the urinary system, in Withrow “Small Animal Clinical Oncology, 2o ed., WB Saunders, London, 1996.
[110] Yasuda Y, Nagao M, Okano M, Masuda S, Sasaki R, Konishi H, Taninamura T. Localization erythropoietin and erythropoietin-receptor in postimplantation mouse embryos. Dev Growth Diff, 1993; 35: 711-722.
[111] Yoshimura A, Misawa H. Physiology and fuction of the erythropoietin receptor. Curr Opin Hematol, 1998; 5: 171.
